Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study

Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

Hude Quan, Vijaya Sundararajan, Patricia Halfon et al. · Medical Care · 2005 · 10.6K citations

Health Professions, Internal Medicine, Clinical Classification Systems +16

New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race

New England Journal of Medicine · 2021 · 4.1K citations · Full text

Medicine, Nephrology, Clinical Epidemiology +16

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo

Alexander M.M. Eggermont, Michal Kiciński, Christian U. Blank et al. · JAMA Oncology · 2020 · 436 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 366 citations · Full text

Life Sciences, Immunology, Oncology +17

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of Clinical Oncology · 2022 · 317 citations · Full text

Medicine, Immunology, Oncology +17